Kiora Pharmaceuticals (KPRX) Receivables - Net (2024 - 2025)
Kiora Pharmaceuticals (KPRX) has disclosed Receivables - Net for 2 consecutive years, with $1.2 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Receivables - Net fell 31.97% year-over-year to $1.2 million, compared with a TTM value of $1.2 million through Sep 2025, down 31.97%, and an annual FY2024 reading of $601197.0, changed N/A over the prior year.
- Receivables - Net was $1.2 million for Q3 2025 at Kiora Pharmaceuticals, down from $2.4 million in the prior quarter.
- Across five years, Receivables - Net topped out at $2.4 million in Q2 2025 and bottomed at $189905.0 in Q1 2024.